These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 18689909

  • 1. Malignant aldosterone-producing adrenal tumour: reoccurrence with glucocorticoid excess without hyperaldosteronism.
    Abma EM, Kluin PM, Dullaart RP.
    Neth J Med; 2008 Jun; 66(6):252-5. PubMed ID: 18689909
    [Abstract] [Full Text] [Related]

  • 2. Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
    Kurtulmus N, Yarman S, Azizlerli H, Kapran Y.
    Horm Res; 2004 Jun; 62(2):67-70. PubMed ID: 15218335
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism].
    Vonend O, Stegbauer J, Kokulinsky P, Adams S, Liermann D, Hahn K, Rump LC.
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2436-41. PubMed ID: 17987550
    [Abstract] [Full Text] [Related]

  • 4. Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
    Myint KS, Watts M, Appleton DS, Lomas DJ, Jamieson N, Taylor KP, Coghill S, Brown MJ.
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):103-6. PubMed ID: 18584586
    [Abstract] [Full Text] [Related]

  • 5. [Isolated primary hyperaldosteronism caused by adrenocortical carcinoma].
    Parajó A, Fírvida JL, Otero E, García M, Montero M.
    Arch Esp Urol; 2000 Dec; 53(10):931-4. PubMed ID: 11213398
    [Abstract] [Full Text] [Related]

  • 6. [Causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and strategy therefore].
    Yan QZ, Li HZ, Pan DL.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 14; 86(42):3002-4. PubMed ID: 17288816
    [Abstract] [Full Text] [Related]

  • 7. Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing primary hyperaldosteronism.
    Deckers S, Derdelinckx L, Col V, Hamels J, Maiter D.
    Horm Res; 1999 Nov 14; 52(2):97-100. PubMed ID: 10681640
    [Abstract] [Full Text] [Related]

  • 8. Hyperaldosteronism: sampling the adrenal veins.
    Doppman JL, Gill JR.
    Radiology; 1996 Feb 14; 198(2):309-12. PubMed ID: 8596821
    [No Abstract] [Full Text] [Related]

  • 9. Adrenocortical carcinoma, an unusual cause of secondary hypertension.
    Veron Esquivel D, Batiz F, Farias Vega A, Carrillo Gonzalez PA.
    BMJ Case Rep; 2016 Dec 07; 2016():. PubMed ID: 27927710
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients.
    Abdelhamid S, Müller-Lobeck H, Pahl S, Remberger K, Bönhof JA, Walb D, Röckel A.
    Arch Intern Med; 1996 Jun 10; 156(11):1190-5. PubMed ID: 8639013
    [Abstract] [Full Text] [Related]

  • 11. Adrenocortical carcinoma initially presenting with hypokalemia and hypertension mimicking hyperaldosteronism: a case report.
    Huang CJ, Wang TH, Lo YH, Hou KT, Won JG, Jap TS, Kuo CS.
    BMC Res Notes; 2013 Oct 08; 6():405. PubMed ID: 24103295
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis and surgical treatment of arterial hypertension of adrenal origin].
    Vetshev PS, Shkrob OS, Ippolitov LI, Polunin GV.
    Khirurgiia (Mosk); 2001 Oct 08; (1):33-40. PubMed ID: 11210311
    [Abstract] [Full Text] [Related]

  • 13. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.
    Abdo A, Bebb RA, Wilkins GE.
    Can J Cardiol; 1999 Mar 08; 15(3):347-8. PubMed ID: 10202199
    [Abstract] [Full Text] [Related]

  • 14. 'Malignant' hypertension from hyperaldosteronism: a case report.
    Baradhi KM, Tran T, Mittadodla PS.
    Pan Afr Med J; 2018 Mar 08; 30():10. PubMed ID: 30123413
    [Abstract] [Full Text] [Related]

  • 15. Malignant acanthosis nigricans in adrenal carcinoma.
    Hiranandani M, Kaur I, Singhi SC, Bhoria U.
    Indian Pediatr; 1995 Aug 08; 32(8):920-3. PubMed ID: 8635841
    [No Abstract] [Full Text] [Related]

  • 16. Newly developed hypertension as an early marker of recurrence of adrenocortical carcinoma with high renin expression.
    Wen MJ, Lin YF, Chen JS.
    Int J Urol; 2008 Jun 08; 15(6):540-2. PubMed ID: 18489644
    [Abstract] [Full Text] [Related]

  • 17. [Therapy-resistant hypertension--the endocrinological view].
    Beuschlein F, Reincke M.
    MMW Fortschr Med; 2007 Mar 01; 149(9):29-32. PubMed ID: 17612246
    [Abstract] [Full Text] [Related]

  • 18. Aldosterone-producing adrenocortical carcinoma without hypertension.
    Song MS, Seo SW, Bae SB, Kim YJ, Kim SJ.
    Korean J Intern Med; 2012 Jun 01; 27(2):221-3. PubMed ID: 22707896
    [Abstract] [Full Text] [Related]

  • 19. [Determining aldosterone in the adrenal veins in order to establish uni- or bilateral aldosterone production in patients with primary hyperaldosteronism].
    Freriks K, Schultze Kool LJ, Timmers HJ, Deinum J, Lenders JW, Hermus AR.
    Ned Tijdschr Geneeskd; 2007 May 05; 151(18):1029-34. PubMed ID: 17508690
    [Abstract] [Full Text] [Related]

  • 20. [Malignant aldosteronoma in the differential diagnosis of Conn syndrome].
    Ludvik B, Niederle B, Roka R, Schernthaner G, Neuhold N.
    Acta Med Austriaca; 1988 May 05; 15(4):117-20. PubMed ID: 3213380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.